Van Linthout, S., Spillmann, F., Lorenz, M., Meloni, M., Jacobs, F., Egorova, M., Stangl, V., De Geest, B., Schultheiss, H.-P. and Tschope, C. (2009) Vascular-protective effects of high-density lipoprotein include the downregulation of the angiotensin II type 1 receptor. Hypertension, 53(4), pp. 682-687. (doi: 10.1161/HYPERTENSIONAHA.108.118919)
Full text not currently available from Enlighten.
Publisher's URL: http://dx.doi.org/10.1161/HYPERTENSIONAHA.108.118919
Abstract
There is growing evidence that a cross-talk exists between the renin-angiotensin (Ang) system and lipoproteins. We investigated the role of high-density lipoprotein (HDL) on Ang II type 1 receptor (AT1R) regulation and subsequent Ang II–mediated signaling under diabetic conditions. To investigate the effect of HDL on AT1R expression in vivo, apolipoprotein A-I gene transfer was performed 5 days after streptozotocin injection. Six weeks after apolipoprotein A-I gene transfer, the 1.9-fold (P=0.001) increase of HDL cholesterol was associated with a 4.7-fold (P<0.05) reduction in diabetes mellitus–induced aortic AT1R expression. Concomitantly, NAD(P)H oxidase activity, Nox 4, and p22<sup>phox</sup> mRNA expression were reduced 2.6-fold, 2.0-fold, and 1.5-fold (P<0.05), respectively, whereas endothelial NO synthase dimerization was increased 3.3-fold (P<0.005). Apolipoprotein A-I transfer improved NO bioavailability as indicated by ameliorated acetylcholine-dependent vasodilation in the streptozotocin-Ad.hapoA-I group compared with streptozotocin-induced diabetes mellitus. In vitro, HDL reduced the hyperglycemia-induced upregulation of the AT1R in human aortic endothelial cells. This was associated with a 1.3-fold and 2.2-fold decreases in reactive oxygen species and NAD(P)H oxidase activity, respectively (P<0.05). Finally, HDL reduced the responsiveness to Ang II, as indicated by decreased oxidative stress in the hyperglycemia+HDL+Ang II group compared with the hyperglycemia+Ang II group. In conclusion, vascular-protective effects of HDL include the downregulation of the AT1R.
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Meloni, Dr Marco |
Authors: | Van Linthout, S., Spillmann, F., Lorenz, M., Meloni, M., Jacobs, F., Egorova, M., Stangl, V., De Geest, B., Schultheiss, H.-P., and Tschope, C. |
College/School: | College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health |
Journal Name: | Hypertension |
Publisher: | American Heart Association |
ISSN: | 0194-911X |
ISSN (Online): | 1524-4563 |
University Staff: Request a correction | Enlighten Editors: Update this record